7,8‐Dihydr­oxy‐4‐propyl‐1,2,3,4,4a,5,6,10b‐octa­hydro­benzo[f]quinolinium bromide monohydrate,a dopamine agonist

In the crystal structure of the title dopamine­rgic compound, C₁₆H₂₄NO₂⁺·Br⁻·H₂O, protonation occurs at the piperidine N atom. The piperidine ring adopts a chair conformation and the cyclo­hexene ring adopts a half‐chair conformation; together with the planar benzene ring, this results in a relatively planar shape for the whole mol­ecule. Classical hydrogen bonds (N—H⋯Br, O—H⋯Br and O—H⋯O) produce an infinite three‐dimensional network. Hydrogen bonds between water ­mol­ecules and Br⁻ anions create centrosymmetric rings throughout the crystal structure. Structural comparison of the mol­ecule with the ergoline dopamine agonist pergolide shows that it is the hydrogen‐bond‐forming hydr­oxy or imino group that is necessary for dopamine­rgic activity, rather than the presence of a phenyl or a pyrrole ring per se.